| Senator Boxer: Senators Boxer, Lautenberg and Kerry Introduce ...
June 29, 2007 -- Washington, D.C. – U.S. Senators Barbara Boxer (D-CA), Frank Lautenberg (D-NJ) and John Kerry (D-MA) yesterday introduced legislation to develop new technologies in the fight against prostate cancer. “This much needed legislation mirrors the investment the Federal government made years back in advanced imaging technologies for detection, diagnosis and treatment of breast cancer. We all know that investment in technology has saved many lives," Senator Boxer said. "New technologies are our best weapon in the fight to find a cure for cancer," Senator Kerry said. "This legislation will put the resources behind the medicine and the science, and ensure we do everything possible to find a cure. As a prostate cancer survivor I know in a personal way how the early detection and innovative treatment can save lives, and I thank Senators Boxer and Lautenberg for their leadership on this issue." Prostate cancer is the second most common cancer in the United States and the second leading cause of cancer related deaths in men.
Pharmatech, Inc. Selects OmniComm Systems, Inc. as Its Preferred ...
FT. LAUDERDALE, FL -- 07/02/07 -- OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Pharmatech, Inc., a Research Management Organization (RMO), to build a patient registry database that will improve patient accrual in clinical trials. The database will leverage the data mining functionality inherent in OmniComm's First in Functionality TrialMaster® EDC solution to facilitate the screening and identification of patient candidates for cutting-edge oncology research. OmniComm will be the exclusive choice for Pharmatech and their network physicians who utilize EDC for clinical trials. Pharmatech will begin using TrialMaster in a multi-center, Phase II clinical trial for advanced Non-Small Cell Lung Cancer (NSCLC).
'Virtual Patient' To Simulate Real-time Organ Motions For ...
Science Daily With a $2 million grant from the National Institutes of Health (NIH), researchers from Rensselaer Polytechnic Institute are developing a physics-based virtual model that can simulate a patient's breathing in real time. When used in conjunction with existing 3-D models, adding the fourth dimension of time could significantly improve the accuracy and effectiveness of radiation treatment for lung and liver cancers. .
|
